News

Nasdaq3y
Creative Medical (CELZ) Up 82% on Stem Cell Treatment Data
Shares of Creative Medical Technology Holdings, Inc. CELZ skyrocketed more than 80% after it announced topline data from a two-year follow-up pilot study on StemSpine, a patented procedure for ...
Nasdaq3y
Creative Medical Technology Holdings Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to The Nasdaq Capital Market
PHOENIX, Nov. 9, 2021 /PRNewswire/ -- (OTC-CELZ) Creative Medical Technology Holdings, Inc. (the "Company"), a commercial stage biotechnology company focused on immunology, urology, neurology and ...
Business Insider4mon
Creative Medical Technology reports one-year results for AlloStem program - Markets Insider
Creative Medical Technology (CELZ) announced one-year follow-up data from the AlloStem Type 2 Diabetes pilot study for late-stage patients. CELZ-201 is an off the shelf, ready-to-use universal and ...
Business Insider4y
Creative Medical Technology Holdings files Patent on Induction of Infectious Tolerance by Ex Vivo Reprogrammed Immune Cells Utilizing ImmCelz® Cellular Immunotherapy | Markets ...
PHOENIX, Dec. 10, 2020 /PRNewswire/ -- Creative Medical Technology Holdings trading under the ticker symbol CELZ announced today its patent filing based on data covering utilization of the Company ...